Add to Calendar

Register Now

Thursday, December 3rd 7:00 p.m. EST.

As a result of participating in this activity, learners will be able to: Discuss the role of sialoendoscopy for the management of inflammatory and obstructive salivary disorders, identify appropriate, "patient tailored" management of benign parotid and submandibular tumors, and review treatment options for salivary gland malignancies.

The target audience for this presentation: Otolaryngologists, Primary Care, Dentists, Oral Surgeons, Rheumatologists, Radiation Oncologists, and Medical Oncologists


CME statement:

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

USF Health designates this enduring activity for a maximum of 1 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USF Health (provider number 2970) is an approved provider of continuing education for nurses through Florida Board of Nursing. This activity has been approved for 1.0 contact hours.


View related document for accreditation information.



If you have any questions or credit related inquiries, please contact USF Health at


December 3, 2020

Created by

Tampa General Hospital


Matthew Mifsud, MD FACS

Matthew Mifsud, MD FACS

Assistant Professor
USF Department of Otolaryngology H&N Surgery
Division of Head & Neck Oncology & Microvascular Surgery
Director Center for Salivary Gland Surgery